DarioHealth
DRIO
14 hedge funds and large institutions have $442K invested in DarioHealth in 2017 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 0 closing their positions.
56% more funds holding
Funds holding: 9 → 14 (+5)
45% more capital invested
Capital invested by funds: $305K → $442K (+$137K)
0% more ownership
Funds ownership: 0% → 0.01% (+0%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$178K |
| 2 |
WPC
Waters Parkerson & Co
New Orleans,
Louisiana
|
+$33.9K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$25.1K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$6.09K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BA
Bard Associates
Chicago,
Illinois
|
-$26.4K |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$6.09K |
DRIO Hedge Fund Activity: Q4 2017 in Review
14 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in DarioHealth (DRIO) for Q4 2017, worth a combined $442K — up 45% from $305K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new DRIO positions and 0 closed out — a net gain of 5 holders — while 0 added to existing stakes and 2 trimmed.
The largest buyer was Anson Funds Management, opening a new position worth an estimated $178K. The largest seller was Bard Associates, cutting an estimated $26.4K.
- 14 institutional investors held DarioHealth (DRIO) as of Q4 2017, up from 9 in Q3 2017.
- Funds reported $442K of DarioHealth stock for Q4 2017, up 45% quarter-over-quarter.
- 5 funds opened new DarioHealth positions in Q4 2017 and 0 closed out, a net change of +5 holders.
- The largest DarioHealth buyer in Q4 2017 was Anson Funds Management, an estimated $178K added.
- The largest DarioHealth seller in Q4 2017 was Bard Associates, an estimated $26.4K sold.
Based on aggregated 13F filings for Q4 2017.